Inflammation, rather than amyloid and tau, could be at the root, a new study suggests
Rafaat Rahmani, CEO of Lifescience Dynamics, discusses current trends in drugs approval and why a resurgence is being seen in provision for Alzheimer's Historically, market authorisations for...
Research project launched to create new test, as survey reveals positive public response to development
New research shows how little the condition is understood - despite 1m people currently living with it
Deep learning framework can help maximise outcomes for those with mild cognitive impairment
Trials of donanemab have shown its potential in slowing progress of early-stage Alzheimer's disease
Study raises question of whether better pain management could improve quality of life
Alzheimer’s Research UK and Race Against Dementia join forces and commit £500,000 to fund research
Repeated exposure to blasts among military personnel can heighten risk of Alzheimer's, research reveals
The GFAP protein could help in the earlier detection of the dementia, and could support early intervention
